Canada markets open in 6 minutes

Mydecine Innovations Group Inc. (0NF0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0100-0.0005 (-4.76%)
As of 08:01AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
7.493
0
7.493
2.617
125.572
Cost of Revenue
-
0
0
0
94.048
Gross Profit
-
0
7.493
2.617
31.524
Operating Expenses
Research Development
4,247
3,589
3,960
1,291
0
Selling General and Administrative
15,692
9,821
13,819
7,360
3,204
Total Operating Expenses
20,168
16,389
22,692
11,462
3,426
Operating Income or Loss
-20,160
-16,389
-22,684
-11,459
-3,394
Interest Expense
742.445
911.594
205.267
182.866
80.517
Total Other Income/Expenses Net
-1,766
59.158
-693.508
-15,234
-17,955
Income Before Tax
-22,669
-17,242
-23,583
-26,876
-21,429
Income from Continuing Operations
-22,669
-17,242
-23,583
-26,876
-21,429
Net Income
-22,353
-11,567
-28,897
-26,949
-21,429
Net Income available to common shareholders
-22,353
-11,567
-28,897
-26,949
-21,429
Basic EPS
-1.20
-1.34
-6.17
-12.05
-48.00
Diluted EPS
-1.20
-1.34
-6.17
-12.05
-48.00
Basic Average Shares
45,207
8,647
4,682
2,274
445.465
Diluted Average Shares
45,207
8,647
4,682
2,274
445.465